Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001186474 | SCV001352908 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-01-06 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001812239 | SCV001472076 | likely benign | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001186474 | SCV001635012 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-06-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001186474 | SCV002714504 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001812239 | SCV004699857 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | TGFBR2: BP4, BP7 |
Prevention |
RCV003953572 | SCV004770449 | likely benign | TGFBR2-related condition | 2019-07-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |